Evidence map›Paper›PMID 21273440›Full record

ArticleMolecular endocrinology (Baltimore, Md.)2011

Ligand-dependent degradation of SRC-1 is pivotal for progesterone receptor transcriptional activity.

Larbi Amazit, Audrey Roseau, Junaid A Khan, Anne Chauchereau, Rakesh K Tyagi, Hugues Loosfelt, Philippe Leclerc, Marc Lombès, Anne Guiochon-Mantel

Open access · bronzeAbstract read
In one paragraph

Article in Molecular endocrinology (Baltimore, Md.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Ubiquitin and proteasomes in transcription.Annual review of biochemistry · 2012
    Review
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Larbi AmazitInstitut National de la Santé et de la Recherche Médicale Unité 693, 63 Rue Gabriel Péri, Le Kremlin-Bicêtre F-94276, France.
Audrey Roseau
Junaid A Khan
Anne Chauchereau
Rakesh K Tyagi
Hugues Loosfelt
Philippe Leclerc
Marc Lombès
Anne Guiochon-Mantel
Bicêtre Hospital · FRBiologie de la Reproduction, Environnement, Epigénétique et Développement · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The progesterone receptor (PR), a ligand-activated transcription factor, recruits the primary coactivator steroid receptor coactivator-1 (SRC-1) gene promoters. It is known that PR transcriptional activity is paradoxically coupled to its ligand-dependent down-regulation. However, despite its importance in PR function, the regulation of SRC-1 expression level during hormonal exposure is poorly understood. Here we report that SRC-1 expression level (but not other p160 family members) is down-regulated by the agonist ligand R5020 in a PR-dependent manner. In contrast, the antagonist RU486 fails to induce down-regulation of the coactivator and impairs PR agonist-dependent degradation of SRC-1. We show that SRC-1 proteolysis is a proteasome- and ubiquitin-mediated process that, predominantly but not exclusively, occurs in the cytoplasmic compartment in which SRC-1 colocalizes with proteasome antigens as demonstrated by confocal imaging. Moreover, SRC-1 was stabilized in the presence of leptomycin B or several proteasomal inhibitors. Two degradation motifs, amino-acids 2-16 corresponding to a PEST motif and amino acids 41-136 located in the basic helix loop helix domain of the coactivator, were identified and shown to control the stability as well as the hormone-dependent down-regulation of the coactivator. SRC-1 degradation is of physiological importance because the two nondegradable mutants that still interacted with PR as demonstrated by coimmunoprecipitation failed to stimulate transcription of exogenous and endogenous target genes, suggesting that concomitant PR/SRC-1 ligand-dependent degradation is a necessary step for PR transactivation activity. Collectively our findings are consistent with the emerging role of proteasome-mediated proteolysis in the gene-regulating process and indicate that the ligand-dependent down-regulation of SRC-1 is critical for PR transcriptional activity.

Indexed as

AnimalsBlotting, WesternCell LineChlorocebus aethiopsCOS CellsHumansImmunohistochemistryImmunoprecipitationMicroscopy, ConfocalNuclear Receptor Coactivator 1Proteasome Endopeptidase ComplexReceptors, ProgesteroneReverse Transcriptase Polymerase Chain ReactionTranscriptional ActivationUbiquitinationNuclear Receptor Coactivator 1Proteasome Endopeptidase ComplexReceptors, Progesterone

Identifiers

PMID21273440
PMCPMC3320859
OpenAlexW2088817213

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.